Furthermore, it has been demonstrated in a clinical analysis that nearly 50% of tissue samples examined from 70 colorectal cancer patients expressed increased levels of cyclin D1 (Utsunomiya et al, 2001). The gene discussed is CCND1; the disease is colorectal cancer.